Crossbow Therapeutics

Cambridge, United States

Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.

$77.0M raised

Mar 2026

Series B

Biotechnology Health Care Life Science Medical Oncology

Top Investors

Libbs Ventures Eli Lilly Polaris Partners Sixty Degree Capital MPM Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Crossbow Therapeutics

How much funding has Crossbow Therapeutics raised?

Crossbow Therapeutics has raised $77.0M in total funding. The most recent round was Series B. The last funding was announced in March 2026.

Who are Crossbow Therapeutics's investors?

Crossbow Therapeutics's investors include Libbs Ventures, Eli Lilly, Polaris Partners, Sixty Degree Capital, MPM Capital.

Where is Crossbow Therapeutics headquartered?

Crossbow Therapeutics is headquartered in Cambridge, United States.

What does Crossbow Therapeutics do?

Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.

What stage is Crossbow Therapeutics at?

Crossbow Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 18, 2026.

MLA

"Crossbow Therapeutics — Funding & Investors." VCBacked, March 18, 2026, https://www.vcbacked.co/company/crossbow-therapeutics. Accessed July 8, 2026.

APA

VCBacked. (2026). Crossbow Therapeutics — Funding & Investors. Retrieved July 8, 2026, from https://www.vcbacked.co/company/crossbow-therapeutics

Wikipedia (cite web)

{{cite web |title=Crossbow Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/crossbow-therapeutics |website=VCBacked |access-date=July 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 18, 2026.